Samrat Pharmachem Ltd-$ - 530125 - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2025

Samrat Pharmachem Ltd.

NSE: SAMRATPH | BSE: 530125 | ISIN: INE103E01016 | Industry: Pharmaceuticals
| Expensive Performer

211.6500 3.70 (1.78%)

BSE Apr 13, 2026 15:31 PM

50.20% Fall from 52W High

Volume: 1,470

Samrat Pharmachem Ltd.

14 Nov 2025

211.65

1.78%

Result

Samrat Pharmachem Ltd-$ - 530125 - Un-Audited Financial Results For The Quarter And Half Year Ended …

BSE India

Un-audited financial results for the quarter and half year ended 30th September, 2025

More from Samrat Pharmachem Ltd.

Recommended

IPO market defies volatility with 3 positive listings last week, and 4 more lined up

| 13 Apr 2026, 06:18PM

Market closes lower after US-Iran ceasefire talks fall through

Trendlyne Marketwatch | 13 Apr 2026, 03:55PM

Dividend yields vary across sectors, but Indian IT comes out on top

The Baseline | 10 Apr 2026